Biotech’s New Frontiers: ALS, Alzheimer’s, and More
Kilder
- STAT: Regenxbio says Duchenne gene therapy succeeded in clinical trial, paving way for FDA submission - statnews.com
- Fierce Biotech: Regenxbio reaps pivotal win for Duchenne gene therapy - Fierce Biotech
- BioPharma Dive: With new data, Regenxbio to seek FDA approval of Duchenne gene therapy - BioPharma Dive
- BioSpace: Biogen Completes Acquisition of Apellis Pharmaceuticals - BioSpace
- Bioworld: Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal - BioWorld News
- Bioworld: Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal - BioWorld News
- Biz: Aribio licenses Alzheimer drug to Fosun Pharma in $4.7b global deal - CHOSUNBIZ - Chosunbiz
- Labiotech: immunology Archives - Labiotech.eu
- wikimedia: Photo by Thomasmeany / Wikimedia Commons / CC BY-SA 4.0
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.